Glassman Wealth Services’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-60
Closed -$1K – 1974
2022
Q3
$1K Sell
60
-59
-50% -$781 ﹤0.01% 1415
2022
Q2
$2K Buy
+119
New +$2.03K ﹤0.01% 1241

Other funds holding HCAT

Glassman Wealth Services's HCAT Position: Q4 2022 in Review

Glassman Wealth Services sold out of Health Catalyst (HCAT) in Q4 2022, closing a stake of 60 shares — an estimated $1K sold.

Glassman Wealth Services first reported a position in HCAT in Q2 2022 and held it in 2 quarters. The position peaked at $2K in Q2 2022. 166 funds tracked by Wall St. Rank hold HCAT as of Q4 2022.

  • Glassman Wealth Services reported no remaining Health Catalyst position as of Q4 2022 after selling out during the quarter.
  • Glassman Wealth Services sold 60 Health Catalyst shares in Q4 2022, an estimated $1K.
  • Glassman Wealth Services first reported a position in Health Catalyst in Q2 2022 and held it in 2 quarters.
  • Glassman Wealth Services's Health Catalyst position peaked at $2K in Q2 2022.
  • 166 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2022.

Based on Glassman Wealth Services's 13F filing for Q4 2022, filed 6 Feb 2023.